Effect / research focus
Binds mitochondrial cardiolipin; accelerated U.S. approval covers a narrowly defined rare disease.
Back to the peptide atlas
MitochondriaPeptideApproved for specific uses
Elamipretide
Mitochondrial cardiolipin-binding tetrapeptide
Also known as: SS-31 · Forzinity
How communities discuss it
Discussed in online communities in relation to the research focus described above. Anecdotes are not evidence of efficacy and are not use instructions.
Community reports are anecdotes, not evidence of efficacy or safety.
Why there is no mixing guide here
Reconstitution depends on the exact approved product, its official label and medical supervision. With unapproved substances, identity, concentration, sterility and stability are often unknown. A universal step-by-step guide would therefore be unsafe.
Primary sources
The linked regulator and trial-register sources support the current status summary.